Margaret Katherine Banks sold $94k of HAL
director at HALLIBURTON CO. 3,900 shares at an average of $24.04, traded Mar 4, 2025, filed Mar 5, 2025.
Score components
- +15RoleDirector
- +10Trade size$94k at market
- +10Share of holdings soldSold 27% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-004647, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 4, 2025 | SOpen-market sale Common Stock | -3,900 | $24.04 | $94k | 10,551 | Mar 5, 2025 |
Related signals
Other insiders at HALLIBURTON CO and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | HALLIBURTON CO | Eric Carre EVP & Chief Financial Officer | $929k 24,777 shares | -17% | |
| 54Moderate | HALbuy HALLIBURTON CO | Janet L Weiss director | $169k 8,550 shares | +84% | |
| 52Moderate | HALLIBURTON CO | Eric Carre EVP & Chief Financial Officer | $1.3M 51,179 shares | -29% | |
| 35Weak | HALLIBURTON CO | Timothy McKeon Senior VP and Treasurer | $258k 10,497 shares | -12% | |
| 47Moderate | HALLIBURTON CO | Eric Carre EVP & Chief Financial Officer | $3.7M 141,206 shares | -53% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.